Trials / Recruiting
RecruitingNCT06732596
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Boston Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to improve retention in buprenorphine treatment, a medication used for opioid use disorder, through the use of a smartphone-delivered recovery support intervention. The intervention involves an Embodied Conversational Agent (ECA), a virtual, animated computer agent designed to simulate natural face-to-face conversations. ECAs have been shown to help individuals manage their healthcare in other settings, and this study seeks to evaluate their potential in supporting patients on medication for opioid use disorder (MOUD).
Detailed description
One hundred participants will be enrolled in the study from the Office-Based Addiction Treatment (OBAT) clinic at Boston Medical Center (BMC). The participants will be randomly assigned to one of two groups. In the intervention group, participants will engage in ECA use and will receive (1) technical support, (2) text message reminders, and (3) monetary incentives. Alternatively, participants will be randomized to the treatment as usual group where they do not access the ECA application. Assessments will be conducted in person at baseline and over the phone at 6 months and 12 months. At 3 and 9 months, research staff will make brief telephone contacts to confirm or update participant contact information. The primary outcome is retention in buprenorphine treatment over 12 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Embodied conversational agent (ECA) | The app with the ECA will be provided. |
| OTHER | Technical support | Technical support will include assistance downloading and setting up the app on the participant's phone, walking them through a brief demonstration, and answering any questions the participant has about how to use the app. |
| OTHER | Additional ECA messages | Weekly text messages will be provided reminding participants to use the app on behalf of OBAT clinical staff. |
| OTHER | Additional incentives | Additional incentives will be provided after logging into the app for 20 days followed by monthly lotteries for those who log in 15 days per month |
Timeline
- Start date
- 2025-10-30
- Primary completion
- 2026-12-01
- Completion
- 2026-12-01
- First posted
- 2024-12-13
- Last updated
- 2025-11-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06732596. Inclusion in this directory is not an endorsement.